VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BLTE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BLTEBelite Bio, Inc
$157.69$6.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBLTEQuarterly Financials

Belite Bio, Inc (BLTE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Belite Bio, Inc (BLTE) quarterly income statement — complete revenue, gross profit & net income history

BLTE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses28.08M17.6M15.52M11.46M9.74M10.47M8.33M6.96M10.96M6.87M6.88M6.72M2.54M2.51M1.05M2.5M2.5M2.4M2.4M1.82M
OpEx % of Revenue--------------------
Selling, General & Admin13.45M6.55M6.12M4.2M2.9M1.39M1.56M2.09M2.22M1.35M1.16M1.5M1.35M927K175K610K610K579K579K431.5K
SG&A % of Revenue--------------------
Research & Development14.63M11.05M9.4M7.25M6.84M9.08M6.76M4.86M8.74M5.52M5.72M5.23M1.19M1.58M878K1.89M1.89M1.82M1.82M1.38M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-28.08M-17.6M-15.52M-11.46M-9.74M-10.47M-8.33M-6.96M-10.96M-6.87M-6.88M-6.72M-2.54M-2.51M-1.05M-2.5M-2.5M-2.4M-2.4M-1.82M
Operating Margin %--------------------
Operating Income Growth %-145.06%-68.05%-86.32%-64.73%11.14%-52.39%-21.03%-3.48%-331.54%-174.18%-553.47%-168.89%-1.62%-4.46%56.11%-37.64%-37.64%-127.29%-127.29%-
EBITDA-28.08M-17.55M-15.47M-7.58M-9.71M-10.44M-8.29M-6.88M-10.95M-6.81M-6.89M-6.53M-2.4M-2.39M-1.07M-2.49M-2.49M-2.39M-2.39M-1.81M
EBITDA Margin %--------------------
EBITDA Growth %-270.46%-68.2%-86.6%-10.08%11.33%-53.27%-20.38%-5.4%-355.47%-184.78%-543.83%-162.12%3.57%0.02%55.26%-37.57%-37.57%-127.44%-127.44%-
D&A (Non-Cash Add-back)11742K42K034.75K34.75K34.75K016K0000007.5K7.5K7.5K7.5K4.5K
EBIT-30.68M-16.32M-14.28M-7.58M-8.68M-9.49M-7.87M-6.88M-10.93M-6.81M-6.89M-6.53M-2.4M-2.39M-1.07M-2.47M-2.47M-2.36M-2.4M-1.82M
Net Interest Income00000000000-32.75K000-500000-5.25K
Interest Income0000000000-400000000
Interest Expense0000000000-32.75K0005000005.25K
Other Income/Expense2.75M1.28M1.24M1.36M1.06M977K463K-36K27K62K-8K-63K137K115K-17K27K27K38.5K38.5K-4.5K
Pretax Income-25.32M-16.32M-14.28M-10.1M-8.68M-9.49M-7.87M-6.99M-10.93M-6.81M-6.89M-6.78M-2.4M-2.39M-1.07M-2.47M-2.47M-2.36M-2.36M-1.82M
Pretax Margin %--------------------
Income Tax0000006K-1K1K3K6K000000000
Effective Tax Rate %0%0%0%0%0%0%-0.08%0.01%-0.01%-0.04%-0.09%0%0%0%0%0%0%0%0%0%
Net Income-25.32M-16.32M-14.28M-10.1M-8.68M-9.49M-7.87M-6.99M-10.94M-6.81M-6.89M-6.78M-2.4M-2.39M-1.07M-2.47M-2.47M-2.36M-2.36M-1.82M
Net Margin %--------------------
Net Income Growth %-150.73%-71.9%-81.39%-44.49%20.63%-39.37%-14.16%-3.04%-355.06%-184.9%-544.39%-174.38%2.81%-1.29%54.67%-35.81%-35.81%-123.53%-123.53%-
Net Income (Continuing)-25.32M-16.32M-14.28M-10.1M-8.68M-9.49M-7.87M-6.99M-10.94M-6.81M-6.89M-6.78M-2.4M-2.39M-1.07M-2.47M-2.47M-2.36M-2.36M-1.82M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.72-0.50-0.44-0.32-0.28-0.31-0.27-0.25-0.40-0.26-0.33-0.30-0.10-0.12-0.04-0.26-0.26-0.25-0.25-0.21
EPS Growth %-125%-61.29%-62.96%-28%30%-19.23%18.18%16.67%-300%-116.67%-643.24%-15.38%61.54%52%82.24%-23.81%-23.81%-108.33%-108.33%-
EPS (Basic)-0.72-0.50-0.44-0.32-0.28-0.31-0.27-0.25-0.40-0.26-0.33-0.30-0.10-0.12-0.04-0.26-0.26-0.25-0.25-0.21
Diluted Shares Outstanding33.54M32.59M32.08M31.45M30.69M30.32M29.68M28.32M27.32M25.79M20.95M22.42M24.87M19.66M24.1M9.57M9.57M9.57M9.57M8.84M
Basic Shares Outstanding33.54M32.59M32.08M31.45M30.69M30.32M29.68M28.32M27.32M25.79M20.95M22.42M24.87M19.66M24.1M9.57M9.57M9.57M9.57M8.84M
Dividend Payout Ratio--------------------